What is the significance of the FDA Reauthorization Act of 2017?

The FDA Reauthorization Act of 2017 is significant because it mandated the FDA to establish regulations for over-the-counter (OTC) hearing aids within a three-year timeframe. This legislation aimed to improve accessibility and affordability for individuals with hearing impairments by allowing them to purchase hearing aids without needing a prescription from a medical professional. The creation of OTC regulations was intended to support consumer empowerment, enabling people to take charge of their hearing health without unnecessary barriers and potentially reducing costs associated with obtaining hearing aids.

The act did not make hearing aids illegal, limit sales strictly to medical professionals, or convert all hearing aids into prescription-only devices. Instead, it recognized the growing need for more accessible hearing solutions and initiated steps to allow for a broader market for over-the-counter options, thus aligning with contemporary practices and consumer demand.